DIAGNOS TICS
organisation. Overall, the new testing strategy is keeping women safe, giving their families reassurance, and obstetricians the extra security of making clear evidence- based decisions.
CSJ
References 1. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health 4 (2014) 97-104. http://
dx.doi.org/10.1016/j.preghy.2014.02.001
2. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987- 2004. Am J Hypertens. 2008; 21(5):521–526. DOI: 10.1038/ajh.2008.20 [PubMed: 18437143]
3. Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol. 2009; 33(3):130– 137. DOI: 10.1053/
j.semperi.2009.02.010 [PubMed: 19464502]
https://pubmed.ncbi.nlm.nih. gov/19464502/
4. Arun Jeyabalan, Epidemiology of preeclampsia: Impact of obesity. Nutr Rev. 2013 October ; 71(0 1): doi:10.1111/nure.12055.
5. Tommy’s.
https://www.tommys.org/pregnancy- information/pregnancy-complications/pre- eclampsia
6. Karrar S, Hong PL. Preeclampsia. [Updated 2021 Nov 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available
from:
https://www.ncbi.nlm.nih.gov/books/ NBK570611/
https://www.ncbi.nlm.nih.gov/ books/NBK570611/#:~:text=Preeclampsia%20 and%20eclampsia%20account%20for%20 greater%20than%2050%2C000,26%25%20 of%20maternal%20death%20among%20this%20 population.%20
7. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Who is at risk of pre-eclampsia.
https://www.nichd.nih.gov/health/ topics/preeclampsia/conditioninfo/risk
8. Rachael Fox, Jamie Kitt, Paul Leeson, Christina Y.L. Aye and Adam J. Lewandowski. Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. J. Clin. Med. 2019, 8, 1625. doi:10.3390/jcm810162
9. Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33(2):237-v. doi:10.1016/j. rdc.2007.01.002
10. Kate E Duhig, Jenny Myers, Paul T Seed, Jenie Sparkes, Jessica Lowe, Rachael M Hunter et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. The Lancet, May 2019, vol 393, issue 10183, 1807-1818 doi: 10.1016/SO140- 6736(18)33212-4
11. National Institute for Health and Care Excellence (NICE). (2019). Hypertension in pregnancy: diagnosis and management. NG133. Available at:
www.nice.org.uk/guidance/ng133 (Accessed: 19 May 2022).
About the author
Dawn Hannah is clinical educator for Quidel in the UK and Ireland. A registered nurse and midwife, she has worked in anaesthetics and as an advanced practice midwife, as well as within primary and secondary care management in a variety of roles, including NHS England. She holds a Dip He, BSc(hons), MSc, MBA and PhD, and has been published in both nursing and midwifery journals. Her current role is to support healthcare providers in the adoption and use of placental growth factor testing, both in the UK and globally.
Please visit us at Medica Hall 14 D16
62 l
WWW.CLINICALSERVICESJOURNAL.COM
JANUARY 2023
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
